All In MedTech

Device Trial Radar · NCT03173664

Post-Approval Study With the KAMRA Inlay

Post-Approval Study of Clinical Outcomes and Visual Symptoms With the KAMRA Inlay

Last checked: Nov 19, 2026Latest source record: May 18, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

529

Planned (sponsor's estimate)

Start

Jul 31, 2018

Primary completion

Jan 2026

Study completion Jan 2026

Sponsor

Lead sponsor
AcuFocus, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 2, 2017

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 45 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

KAMRA inlay, to be unilaterally implanted into the cornea of a subject's non-dominant eye. The inlay is to be inserted into a stromal pocket created with a surgical femtosecond laser.

Conditions

  • Presbyopia

Interventions

  • KAMRA InlayDevice

    Unilateral implantation of the KAMRA inlay in the corneal stroma.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Monocular Near Visual AcuityTime frame: Five years

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.